Peripapillary choroidal atrophy in sympathetic ophthalmia and management with triple-agent immunosuppression

Abstract

Purpose: To describe the occurrence of peripapillary choroidal atrophy and experience with triple-agent immunosuppression in three cases of sympathetic ophthalmia. Materials and methods: Retrospective chart review of three cases of sympathetic ophthalmia with peripapillary choroidal atrophy. Results: Three patients with sympathetic ophthalmia were managed with steroid pulse therapy and triple-agent immunosuppression. All three patients subsequently developed peripapillary choroidal atrophy. Conclusions: Peripapillary choroidal atrophy can occur in sympathetic ophthalmia and may indicate a severe form of inflammation which would benefit from triple-agent immunosuppression.